Loading...
Loading...
praxair-canada-receives-approvals-for-noxivent-nitric-oxide-sales-across-the-country
praxair-canada-receives-approvals-for-noxivent-nitric-oxide-sales-across-the-country

Praxair Canada receives approvals for Noxivent nitric oxide sales across the country

0

Praxair Canada Inc., has now gained the necessary approvals to sell its Noxivent brand of inhaled nitric oxide in Canada, thought to be prompted by its latest acquisition.

The Tier One player acquired UK-based business NOxBOX last month, which specialises in manufacturing of inhaled gas delivery and monitoring instruments for the medical market.

Notably, NOxBOX’s NOxBOXiTM system provides intelligent nitric oxide (NOx) delivery for in-hospital use.

The wholly-owned subsidiary’s Noxivent gas is used for the treatment of new-borns up to 34 weeks old, to improve oxygenation in cases of hypoxic respiratory failure.

... to continue reading you must be subscribed

Subscribe Today

Paywall Asset Header Graphic

To access hundreds of features, subscribe today! At a time when the world is forced to go digital more than ever before just to stay connected, discover the in-depth content our subscribers receive every month by subscribing to gasworld.

Please wait...